SBCF vs VRDN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SBCF · Seacoast Bank$33.54 ▼ 0.18%
VRDN · Viridian Therapeutics$28.49 ▼ 0.21%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SBCF +11.0%
- VRDN +3.0%
Head to head
| Metric | SBCF | VRDN |
|---|---|---|
| Price | $33.54 | $28.49 |
| Change today | ▼ 0.18% | ▼ 0.21% |
| Market cap | $3.24B | $3.24B |
| Return, 3 months | -3.1% | +23.5% |
| Return, year to date | +8.7% | -8.5% |
| Return, 1 year | +11.1% | +3.8% |
| P/E (TTM) | 20.0 | – |
| P/B | 1.2 | 6.7 |
| P/E percentile vs own 5y | 71st | 13th |
| Dividend yield | 2.27% | – |
| Revenue growth (YoY, latest qtr) | +36.7% | +278.7% |
| Net profit growth (YoY) | +64.2% | -26.2% |
| Gross margin | – | – |
| Operating margin | – | -569.7% |
| Net margin | 22.4% | -544.1% |
| Return on equity | 7.1% | -86.9% |
| Analyst target vs. price | +8.8% | +19.7% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 53 | 77 |
| 30-day volatility | 23.7% | 67.6% |
| Max drawdown, 1 year | -16.3% | -60.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SBCF is the largest of the group by market value.
- SBCF has returned the most over the past year.
- VRDN is growing revenue fastest.
- SBCF keeps the most profit per dollar of sales.
- SBCF has been the calmest stock over the last 30 days.